Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02867670 · ClinicalTrials.gov registry record

TMS as a Biological Marker of Neuroplasticity

A clinical trial of Stroke and Aphasia, sponsored by University of Pennsylvania.

Completed
Registry status
41
Enrollment target
1
Study location

NCT02867670 is a study of Stroke and Aphasia that has completed, run by University of Pennsylvania. The registered enrollment target is 41 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02867670, a study of Stroke and Aphasia, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
41 participants
Enrollment target
1
Study location

Study Summary

TMS is a non-invasive brain stimulation technique, which can be used to change the activity of a person's brain cells without needles or surgery. In this study, the invesigators are interested in the brain's ability to adapt (also called "neuroplasticity") and regain language functioning after a stroke-specifically, they want to determine whether how a person's brain responds to TMS in the short term can be used to predict how well they will recover language abilities in the long term.

Conditions Studied

Interventions

  • DEVICE Transcranial Magnetic Stimulation

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2013-07
Est. Completion 2020-06

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT02867670

The ClinicalTrials.gov registry entry for NCT02867670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.

NCT02867670 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02867670 about?

NCT02867670 is a clinical study titled "TMS as a Biological Marker of Neuroplasticity". TMS is a non-invasive brain stimulation technique, which can be used to change the activity of a person's brain cells without needles or surgery. In this study, the invesigators are interested in the brain's ability to adapt (also called "neuroplasticity") and regain language functioning after a str...

What is the current status of trial NCT02867670?

This trial is currently completed. The enrollment target is 41 participants. The study started on 2013-07. Estimated completion is 2020-06.

What conditions does trial NCT02867670 study?

This clinical trial studies the following conditions: Stroke, Aphasia.

What interventions are being tested in trial NCT02867670?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT02867670?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02867670 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.